10-K Decoder · All companies

Enanta Pharmaceuticals, Inc.

ENTA · FY2025 · Fiscal year ended Sep 30, 2025 · 10-K filed Nov 2025

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$65.3M$67.6M−3.4%
Operating income−$85.3M−$122M+29.9%
Net income−$81.9M−$116M+29.4%

Latest quarter: Q3 FY2026

Form 10-Q · Three months ended Jun 30, 2026 · filed Aug 12, 2026

$Q3 FY2026Year earlierChange
Revenue$14.4M$18.3M−21.3%
Operating income−$17.2M−$18.9M+9.0%
Net income−$19.5M−$18.3M−6.6%

Q3 FY2026 dashboardQ3 FY2026 infographic

Questions

What was Enanta's revenue in FY2025?
$65.3M in FY2025 (Fiscal year ended Sep 30, 2025), −3.4% vs $67.6M a year earlier, per its 10-K filed Nov 2025.
Was Enanta profitable in FY2025?
No: net income was −$81.9M and operating income −$85.3M in FY2025.
What was Enanta's revenue in Q3 FY2026?
$14.4M (−21.3% vs a year earlier), per its Form 10-Q filed Aug 12, 2026.